These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties. Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186 [TBL] [Abstract][Full Text] [Related]
3. Angiopoietins in tumours: the angiogenic switch. Tait CR; Jones PF J Pathol; 2004 Sep; 204(1):1-10. PubMed ID: 15307132 [TBL] [Abstract][Full Text] [Related]
4. Angiopoietin: a TIE(d) balance in tumor angiogenesis. Shim WS; Ho IA; Wong PE Mol Cancer Res; 2007 Jul; 5(7):655-65. PubMed ID: 17634421 [TBL] [Abstract][Full Text] [Related]
5. A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma. Gardizi M; Kurschat C; Riese A; Hahn M; Krieg T; Mauch C; Kurschat P Arch Dermatol Res; 2012 Jul; 304(5):397-400. PubMed ID: 22410864 [TBL] [Abstract][Full Text] [Related]
6. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins. Plank MJ; Sleeman BD; Jones PF J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783 [TBL] [Abstract][Full Text] [Related]
7. Angiopoietins and angiopoietin-like proteins in angiogenesis. Morisada T; Kubota Y; Urano T; Suda T; Oike Y Endothelium; 2006; 13(2):71-9. PubMed ID: 16728326 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365 [TBL] [Abstract][Full Text] [Related]
10. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum? Balasubramanian SP; Reed MW Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237 [TBL] [Abstract][Full Text] [Related]
11. Tumorigenesis and the angiogenic switch. Bergers G; Benjamin LE Nat Rev Cancer; 2003 Jun; 3(6):401-10. PubMed ID: 12778130 [TBL] [Abstract][Full Text] [Related]
12. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Eklund L; Olsen BR Exp Cell Res; 2006 Mar; 312(5):630-41. PubMed ID: 16225862 [TBL] [Abstract][Full Text] [Related]
13. The role of angiopoietin-like proteins in angiogenesis and metabolism. Hato T; Tabata M; Oike Y Trends Cardiovasc Med; 2008 Jan; 18(1):6-14. PubMed ID: 18206803 [TBL] [Abstract][Full Text] [Related]
14. Effect of CDT6 on factors of angiogenic balance in tumour cell lines. Bouïs DR; Dam WA; Meijer C; Mulder NH; Hospers GA Anticancer Res; 2007; 27(4B):2325-9. PubMed ID: 17695521 [TBL] [Abstract][Full Text] [Related]
15. The role of the Angiopoietins in vascular morphogenesis. Thomas M; Augustin HG Angiogenesis; 2009; 12(2):125-37. PubMed ID: 19449109 [TBL] [Abstract][Full Text] [Related]
16. Tumour-associated angiogenesis in human colorectal cancer. Rmali KA; Puntis MC; Jiang WG Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841 [TBL] [Abstract][Full Text] [Related]